gp91 ds-tat
CAS No. 329902-61-6
gp91 ds-tat( —— )
Catalog No. M37261 CAS No. 329902-61-6
gp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 73 | Get Quote |
|
| 5MG | 141 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namegp91 ds-tat
-
NoteResearch use only, not for human use.
-
Brief Descriptiongp91 ds-tat is a NADPH oxidase (NOX2) inhibitor that reduces NOX2 expression.
-
Descriptiongp91 ds-tat is a biological active peptide. (NADPH oxidase assembly peptide inhibitor)
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetNADPH
-
RecptorNADPH-oxidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number329902-61-6
-
Formula Weight2452.94
-
Molecular FormulaC98H190N50O22S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N)=O)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)(NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)CCCCN)=O)CCCCN)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCC(N)=O)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CCCNC(=N)N)=O)CS)=O)CO)=O)[C@@H](C)O)=O)CCCNC(=N)N)=O)[C@H](CC)C)=O)CCCNC(=N)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
GKT137831
GKT137831 (Setanaxib, GKT-137831) is a potent, selective, dual NADPH oxidase Nox1/4 inhibitor with Ki of 110/140 nM.
-
ML-090
ML-090 is NOX1-specific inhibitor(IC50 = 90 nM) which is >100 selectivity for NOX1 over NOX2, NOX3, NOX4 (all IC50s >10 μM).
-
NoxA1ds
Potent and selective NADPH oxidase 1 (NOX1) inhibitor (IC50 = 20 nM). Exhibits selectivity for NOX1 over NOX2, NOX4, NOX5 and xanthine oxidase. Inhibits NOX1-derived O2- production in HT-29 human colon cancer cells. Attenuates VEGF-induced human pulmonary artery endothelial cell migration under hypoxic conditions in vitro. Cell permeable.
Cart
sales@molnova.com